Murukutla Srujitha, Arora Swaty, Bhatt Vijaya Raj, Kedia Shiksha, Popalzai Muhammad, Dhar Meekoo
Department of Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, New York 10305, USA.
Sanford R Nalitt Institute for Cancer and Blood Related Diseases, Department of Medicine, Division of Hematology and Oncology, Staten Island University Hospital, 256 Mason Avenue, Staten Island, New York 10305, USA.
World J Oncol. 2014 Apr;5(2):68-71. doi: 10.14740/wjon722w. Epub 2014 May 6.
Concurrent acute myeloid leukemia (AML) and multiple myeloma (MM) is rare, more so in chemotherapy-naive patients. Concurrent occurrence of these two malignancies portends poor prognosis. Although anthracycline-based AML regimen, allogeneic hematopoietic stem cell transplantation, tipifarnib and bortezomib have shown promising results in small number of patients, there is a lack of established therapy. We describe a case of concurrent AML and MM in a 66-year-old woman and review previously published literature.
同时发生急性髓系白血病(AML)和多发性骨髓瘤(MM)的情况较为罕见,在未经化疗的患者中更是如此。这两种恶性肿瘤同时出现预示着预后不良。尽管基于蒽环类药物的AML治疗方案、异基因造血干细胞移植、替匹法尼和硼替佐米在少数患者中已显示出有前景的结果,但仍缺乏既定的治疗方法。我们描述了一名66岁女性同时患有AML和MM的病例,并回顾了先前发表的文献。